Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms. - Wikidata - wikimedia - TriplyDB

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

http://www.wikidata.org/entity/Q37678047

about

Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS)The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.Importance of Drug Pharmacokinetics at the Site of Action GABA Receptors Genes Polymorphisms and Alcohol Dependence: No Evidence of an Association in an Italian Male Population Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs.Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids.DNA methylation in psychosis: insights into etiology and treatment.Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patterns.Opportunities and limitations: the value of pharmacogenetics in clinical practice.Precision medicine: does ethnicity information complement genotype-based prescribing decisions?Molecular network-selected pharmacogenomics in a case of bipolar spectrum disorder.Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment.Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.

P2860

Q28652508-46D70F43-1F83-495D-B3A6-BBC3206D6E85 Q33635632-2F69490F-5856-4583-813A-4CC891E22C09 Q33648045-7526249A-0B3B-4B54-9B1D-5F6F2FA40D43 Q34129857-DA12D35E-84D4-4C36-A1AE-AD1F276ED717 Q37344778-02CD5207-30FE-4AFC-A8D9-9F45E837BAD0 Q38586847-D0BEED51-4461-46B6-9CBA-A17D7CB3368B Q39038285-BF6FE53D-9757-42DD-BDCB-106F84E5F1F2 Q39329159-08B6CAE9-F5DF-47BE-8556-52EE8343E7B3 Q42383190-98104885-3F12-40D3-B7AC-D0CE20405B63 Q47566249-C2972832-6F57-48D5-986D-03C86756BAB8 Q47573171-00E22D1B-DBE9-4CA7-92A5-69AA0B1978CB Q50156396-C7024A8A-7B5A-46F1-9761-8CDFCE5050BF Q52807144-D0E15068-09AB-4014-9EF1-0C1C4DEC434F

P2860

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

http://www.wikidata.org/entity/Q37678047

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

@en

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

@nl

type

label

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

@en

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

@nl

prefLabel

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

@en

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

@nl

P1433

Q37678047-35E372AF-A907-4317-8FDA-4EDAD7BCC64F

P1476

Q37678047-19615F6C-1261-4F71-BC69-E065FE875D3A

P2093

Q37678047-91A9FFB0-B815-44C5-BE0E-813F1C4F0B94

P2860

Q37678047-02385C78-4DA8-4AB4-824E-6E7210EDECC6

Q37678047-02A4FCB9-2738-4369-8816-DDDEF734B9A4

Q37678047-02C7CF43-EC89-4846-A48D-8A0F92922E94

Q37678047-033D6478-8E14-4420-821D-C626EED70A9B

Q37678047-08DF89AE-C1B5-40EA-8796-BF5474FEF449

Q37678047-09CBBE2B-D60C-45FB-AC0A-6261C0568856

Q37678047-0A60EACE-B677-4727-8C67-20AD6115A47D

Q37678047-0E06914F-4F00-41F1-B3A4-FB6DAF0F5862

Q37678047-106076DA-317D-40BD-B5DA-340CACDD8A75

Q37678047-1197B04B-32B3-40E2-AB0D-2594A55E7FA4

P304

Q37678047-EA35612F-E2C9-48CF-9D38-8B669B0547F3

P31

Q37678047-3E4188B5-12BE-40C8-9654-887B48FED9EE

P356

Q37678047-BECD9091-E3DA-4C1C-A8FD-3172BF51385D

P407

Q37678047-C583F789-F409-4840-9D05-4A40A2FBFB70

P433

Q37678047-1258D1E0-699E-41A2-8AD9-2079B699C555

P478

Q37678047-E461F7FE-8A29-437B-BBD5-AC257B20F67F

P50

Q37678047-E36D4675-0996-41F6-BD99-120622826D9A

Q37678047-FAAAB645-F8E8-4CDD-A517-5DC281598F1C

P577

Q37678047-72C9B7F5-1F41-4B04-9F42-C1A1E851942B

P698

Q37678047-723F6327-4BC1-438E-9DBA-2DB119E96231

P921

Q37678047-33cd5cb3-1f7f-4cec-9499-c3cc0e4eeeea

Q37678047-FEBF7EFD-D0CF-4DAB-B2AA-AE801BEF10C0

P932

Q37678047-F5E6B8F7-C433-4BF4-8F87-EA59E9ED2204

P356

P1433

British Journal of Clinical Pharmacology

P1476

Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.

@en

P2093

Olga O McGowan

http://www.w3.org/2001/XMLSchema#string

P2860

Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis

Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis

Twenty-one-base-pair insertion polymorphism creates an enhancer element and potentiates SLC6A1 GABA transporter promoter activity

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.

Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry.

Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain.

P304

654-672

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.12312

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P50

Gavin P. Reynolds

Caroline F Dalton

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24354796

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

3971982

http://www.w3.org/2001/XMLSchema#string